Activity value 66International Buyer&Supplier,Last transaction date:
2025-05-01
Overview
Import data
Partners
HS Codes
Products
Areas
Ports
Trade trend analysis
Mon
|
Year
Number of TransactionsQuantityWeight
Number of TransactionsQuantityWeight
The above chart presents the market trend analysis for fabiani saude animal ltda. from 2024 to 2025.
By examining various dimensions such as transaction quantity, transaction weight, average price,
and transaction frequency, we can gain an intuitive understanding of the company's performance in terms of procurement cycles, business scale, and stability.
As of 2025, the company has completed 6 transactions, with a transaction quantity of 1 and a transaction weight of 1.
Product description
HORMONAS, PROSTAGLANDINAS, TROMBOXANOS E LEUCOTRIENOS, NATURAIS OU REPRODUZIDOS POR SíNTESE; SEUS DERIVADOS E ANáLOGOS ESTRUTURAIS, INCLUINDO OS POLIPéPTIDOS DE CADEIA MODIFICADA, UTILIZADOS PRINCIPALMENTE COMO HORMONAS|INSUMOS INDUSTRIAIS ELABORADOS|PRODUTOS MANUFATURADOS|FABRICAçãO DE PRODUTOS FARMACêUTICOS, PRODUTOS QUíMICOS MEDICINAIS E BOTâNICOS|HORMONIOS NATURAIS, REPROD.POR SINTESE E SEUS DERIVADOS
Expand
Product description
HORMONAS, PROSTAGLANDINAS, TROMBOXANOS E LEUCOTRIENOS, NATURAIS OU REPRODUZIDOS POR SíNTESE; SEUS DERIVADOS E ANáLOGOS ESTRUTURAIS, INCLUINDO OS POLIPéPTIDOS DE CADEIA MODIFICADA, UTILIZADOS PRINCIPALMENTE COMO HORMONAS|INSUMOS INDUSTRIAIS ELABORADOS|PRODUTOS MANUFATURADOS|FABRICAçãO DE PRODUTOS FARMACêUTICOS, PRODUTOS QUíMICOS MEDICINAIS E BOTâNICOS|HORMONIOS NATURAIS, REPROD.POR SINTESE E SEUS DERIVADOS
Expand
Product description
HORMONAS, PROSTAGLANDINAS, TROMBOXANOS E LEUCOTRIENOS, NATURAIS OU REPRODUZIDOS POR SíNTESE; SEUS DERIVADOS E ANáLOGOS ESTRUTURAIS, INCLUINDO OS POLIPéPTIDOS DE CADEIA MODIFICADA, UTILIZADOS PRINCIPALMENTE COMO HORMONAS|INSUMOS INDUSTRIAIS ELABORADOS|PRODUTOS MANUFATURADOS|FABRICAçãO DE PRODUTOS FARMACêUTICOS, PRODUTOS QUíMICOS MEDICINAIS E BOTâNICOS|HORMONIOS NATURAIS, REPROD.POR SINTESE E SEUS DERIVADOS
Expand
- aeroporto internacional de sao paulo/guarulhos611.11%>
guarulhos47.41%>
sao paulo47.41%>
fabiani saude animal ltda. is International Buyer&Supplier,
and primarily engages in the import and export business of products such as piperazine citrate,ricobendazole,drum.
According to the 52wmb.com global trade database, as of 2025-05-01, the company has completed 54 international trades,
with its main trading regions covering india,other,china etc.
The core products include HS29420090,HS29335915,HS29334900 etc,
often transported via santos,port - aeroporto internacional de sao paulo/guarulhos, port guarulhos etc,
and its main trading partners are adani pharmachem pvt ltd.,hemmo pharmaceuticals pvt ltd.,savino del bene s.p.a..
These trade data are sourced from various countries' customs and public channels, and have undergone standardization and structuring processing.
They can reflect the import and export trends and main market layout of the enterprise, and are suitable for market trend analysis, competitor research, port transportation planning, supply chain optimization, and international customer development.
They provide reliable support for cross-border trade decision-making.
The trade data displayed on fabiani saude animal ltda. is sourced from the 52wmb.com global trade database. It is based on legal records from customs and related public channels of various countries, and has been formatted and organized for user query and analysis.
We maintain compliance with the source and processing of data to ensure the objectivity of information, but due to the dynamic changes in international trade activities, some data may be delayed or changed.